Combined Effects of Nasal Ketamine and Trauma-Focused Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder: A Pilot Case Series.
Judith RohdeElena HickmannMarco BuchmannGolo KronenbergStefan VetterErich SeifritzBirgit KleimSebastian OlbrichPublished in: Behavioral sciences (Basel, Switzerland) (2024)
Despite potential variations in clinical profiles among the patients, the therapy program demonstrated positive outcomes for all participants. Nasally administered ketamine was well tolerated and resulted in immediate symptom reduction in tension, anxiety, and common PTSD symptoms. However, to validate these findings and compare treatment efficacy, future randomized controlled trials are warranted, especially in comparison with trauma-focused therapy alone.
Keyphrases
- end stage renal disease
- randomized controlled trial
- ejection fraction
- chronic kidney disease
- newly diagnosed
- pain management
- social support
- posttraumatic stress disorder
- sleep quality
- trauma patients
- stem cells
- study protocol
- systematic review
- type diabetes
- patient reported
- quality improvement
- insulin resistance
- metabolic syndrome
- risk assessment
- physical activity
- clinical trial
- weight loss
- replacement therapy
- borderline personality disorder